Cystourethroscopes

Welcome to Cystourethroscopes Site

Cystourethroscopes Resources

Home > Cystourethroscopes > ASCB MAC at MBL Lunch Awardees

ASCB MAC at MBL Lunch Awardees

Added the names of all of the ASCB MAC at MBL Lunch Awardees for the years 2002-2006

Click Here to read the entire article...

Other Articles:

•

Five States Step Up Efforts To Screen Newborns For Cystic Fibrosis

Four states-- Arkansas, Kansas, Maine, and West Virginia--have joined 40 others and the District of Columbia in requiring that all newborns be screened for cystic fibrosis (CF) at birth. In addition, Utah has cleared the way to begin regular CF screening as well. Routine screening is expected to begin January 1, 2009.

Click Here to read the entire article...

•

Listen to The Lancet: 21 June

Drug-eluting stents revolutionised interventional cardiology owing to their pronounced ability to reduce restenosis compared with bare-metal stents. Attention has now shifted to safety of these devices because of evidence suggesting an association with late stent thrombosis. In a review, Anthony Bavry and Deepak Bhatt assess current evidence from randomised trials, and propose guidelines for the appropriate use of drug-eluting stents in clinical practice. Deepak Bhatt discusses the history of stents and assesses our current knowledge and considers treatment options for cardiologists and patients in this week's podcast.

Click Here to read the entire article...

•

Zoom RhythmTrak RT-223 - USED

£38.00 (0 Bid)
End Date: Monday Aug-04-2008 22:43:54 BST
Bid now | Add to watch list

Click Here to read the entire article...

•

Medtech Startups, December 2007

New medical technologies represented in companies added (December 2007) to the Medtech Startups Database and/or added to the December 2007 issue of MedMarkets.

The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in MedMarkets Startups during the month of December:

EEG analysis for applications such as detection and prediction of seizure.
Drugs targeting inflammatory and metabolic pathways, including obesity, type 2 diabetes and cardiovascular disease.
In vivo transdifferentiation to regenerate ischemic or diseased organs.
Developing small molecule drugs to reprogram adult stem cells.
Orthopedic devices for pediatric and other small stature patients.
Devices and apparatus for insertion of flexible implants (e.g. breast implants, others).
Implantable devices; e.g., to prevent cerebrospinal fluid leaks.
Minimally invasive spinal instrumentation.
Intra-operative 3D imaging for earlier diagnosis of breast cancer.

Now Published!: Worldwide Wound Management 2007-2016. see link

For coverage in specific issues of MedMarkets, see link.

For details on the Medtech Startups Database, see link.

Tags: medtech, startup

Click Here to read the entire article...

•

Obesity not a contraindication to knee replacement (Reuters)

Reuters - Obese individuals with arthritic knees should not be denied knee replacement surgery, researchers conclude, based on a new study showing that obese patients benefit from the surgery almost as much as their normal-weight peers.

Click Here to read the entire article...

•

[Microbiology] HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision

We previously proposed that mutations in the connection subdomain (cn) of HIV-1 reverse transcriptase increase AZT resistance by altering the...

Click Here to read the entire article...